Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

100,000 UK Volunteers Invited to Donate Genome to Science

Published: Tuesday, November 12, 2013
Last Updated: Tuesday, November 12, 2013
Bookmark and Share
The search for UK volunteers willing to donate their genome and health data to science has begun with the launch today of the Personal Genome Project UK.

PGP-UK, which is directed by Professor Stephan Beck (UCL Cancer Institute), ultimately aims to find 100,000 members of the public willing to take part.

PGP-UK aims to offer every participant analysis of their genome, and every donated genome will potentially enable improvements in personalised medicine. It will be using a novel open consent protocol, enabling genomic data to be linked to medical and health records to create an information-rich resource that is made available under open access, allowing free and unrestricted access.

This means many projects can immediately benefit from PGP-UK data, including the sequencing of 100,000 NHS patients being undertaken by Genomics England to combat diseases such as cancer and other common and rare diseases.

"Donating your genome and health data to science is a great way to enable advances in the understanding of human genetics, biology, and health," said Professor Beck, who has over 30 years experience in genomics and played a leading role in the Human Genome Project.

"This project will establish the practice of open consent in the UK, and enable medical advancement through meeting science’s need for ‘richer’ data. PGP-UK will also engage and educate the UK public on personal genomics and its potential use in medicine.

"Previous work has started the process by giving us vital information on our genes and where and when they are active. Through PGP-UK it will be fascinating to learn how this information translates into the many traits that make us all unique."

Cian Murphy, a PhD Student in Cardiovascular Biomedicine at UCL, has already signed up as a pre-registered volunteer to take part. He said: "Scientists and patients alike suffer from privacy walls. Whether erected for patient security concerns or for less altruistic competitive reasons, they stymy progress and may waste valuable funding repeating independent studies that are perhaps underpowered.

"As the focus of research moves to diseases based on smaller and smaller effects, the research community will need ever more samples. Breaking down these barriers is something I am very eager to support. To that end, I will happily provide my own DNA and medical history. Anonymised or not, I believe the risk in doing so to be minimal and far outweighed by the desired paradigm shift in making this type of data freely available to everyone."

The UK has a strong track record in genomics, most notably as a major contributor to the first sequencing of the human genome by the Human Genome Project in 2000 as part of the international Human Genome Project and the ongoing 1000 Genomes Project. PGP-UK is part of the international Personal Genome Project.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Orchard Therapeutics Launched
UCL and F-Prime launch Orchard Therapeutics to treat rare childhood diseases.
Wednesday, May 04, 2016
Activating Cancer-Killing Immune Cells
A UCL research team have discovered that cutting off a sleep-switch on immune cells inside a tumour wakes up the cells and enables the immune system to hunt down and destroy cancer.
Tuesday, April 19, 2016
Cancer Drug Could Treat Blood Vessel Deformities
A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin.
Monday, April 04, 2016
First Gene for Grey Hair Found
The first gene identified for greying hair has been discovered by an international UCL-led study, confirming greying has a genetic component and is not just environmental. - See more at: https://www.ucl.ac.uk/news/news-articles/0316/010316-first-grey-hair-gene-discovered#sthash.gD0shNNC.dpuf
Thursday, March 03, 2016
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
Wednesday, February 03, 2016
UCL Launches £50 million Technology Investment Fund
UCL is today launching the UCL Technology Fund to invest £50 million in commercialising its world-leading research emerging over the next five years.
Monday, January 25, 2016
DNA ‘Building Blocks’ Pave the Way for Improved Drug Delivery
DNA has been used as a ‘molecular building block’ to construct synthetic bio-inspired pores which will improve the way drugs are delivered and help advance the field of synthetic biology, according to scientists from UCL and Nanion Technologies.
Tuesday, January 19, 2016
First Human Trial for Huntington's Drug
Patients in London are being dosed for the first time with an experimental drug for Huntington’s disease.
Thursday, October 22, 2015
Genes Involved in Schizophrenia and Obesity Highlighted
Genes involved in schizophrenia and obesity have been highlighted in a new UCL study, which could lead to a better understanding of the DNA variants which affect risk of these conditions and aid the development of improved strategies for prevention and treatment.
Monday, October 19, 2015
Possible Evidence for Human Transmission of Alzheimer’s Pathology
Study suggests that under a particular set of circumstances, amyloid-ß may potentially be transmissible through certain medical procedures.
Friday, September 11, 2015
New Variant of Streptococcal Bacteria
Scientists have discovered a new variant of streptococcal bacteria that has contributed to a rise in disease cases in the UK over the last 17 years.
Wednesday, July 15, 2015
Smoking Signs
Research reveals epigenetic alterations caused by smoking.
Wednesday, May 20, 2015
New Biomarkers To Spot Pancreatic Cancer Early
A combination of two biomarkers can identify pre-clinical pancreatic cancer.
Thursday, February 05, 2015
Autolus Launches With £30m Investment
UCL cancer immunotherapy company, Autolus is launches to develop T-cell therapies for haematological and solid tumours.
Thursday, January 22, 2015
Raman Spectroscopy May Enable Non-Invasive Diagnosis of Bone Diseases
Detection of a genetic ‘brittle bone’ disease known as Osteogenesis Imperfecta (OI) is possible by simply scanning a patient’s limbs.
Wednesday, December 03, 2014
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Blood Pressure Drug May Boost Effectiveness of Lung Cancer Treatment
Researchers at Imperial College London have suggested that the blood pressure drug may make a type of lung cancer treatment more effective.
Insight into Eye Diseases
Scientists recreate zebrafish cell regeneration from retinal stem cells in mice.
New Discovery May Benefit Farmers Worldwide
Scientists have shown how a crop-microbe 'team' protect against fungal infection.
Antibodies Paving the Way to HIV Vaccine
Researchers uncover factors responsible for the formation of broadly neutralizing HIV antibodies in humans.
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.
Protein Studies Discover Molecular Secrets
Two protein studies have mapped proteins that reveal the secrets to recycling carbon and healing cells.
Tapping Evolution to Improve Biotech Products
Researchers show how 'ancestral sequence reconstruction' can be used to guide engineering of a blood clotting protein.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!